21:33 , Jan 5, 2018 |  BC Week In Review  |  Financial News

Helix raises C$751K in private placement

Immuno-oncology company Helix BioPharma Corp. (TSX:HBP) said on Dec. 22, 2017, it raised C$750,600 ($589,863) through the sale of units at C$1.20 in a private placement. Each unit comprises a share and a five-year warrant...
19:52 , Jul 28, 2017 |  BC Week In Review  |  Company News

Helix, Moffitt explore data extraction and checkpoint inhibitors with L-DOS47

H. Lee Moffitt Cancer Center and Research Institute (Tampa, Fla.) and Helix BioPharma Corp (TSX:HBP) partnered in two separate deals concerning L-DOS47 from Helix. The first deal involves the extraction of radiomics data from CT...
05:06 , Jun 16, 2017 |  BC Week In Review  |  Financial News

Helix raises C$3M in private placement

On June 7, immuno-oncology company Helix Biopharma Corp. (TSX:HBP) raised C$3 million ($2.3 million) through the sale of units at C$1.20 in a private placement. Each unit comprises a share and a five-year warrant to...
20:50 , Mar 23, 2017 |  BC Week In Review  |  Financial News

Helix completes private placement

On March 16, immuno-oncology company Helix Biopharma Corp. (TSX:HBP) raised C$1.1 million ($824,780) through the sale of 925,000 units at C$1.20 in a private placement. Each unit comprises a share and a five-year warrant to...
19:49 , Mar 3, 2017 |  BC Week In Review  |  Company News

National Research Council Canada, Helix deal

NRC granted Helix worldwide rights to compound 2A3 for cancer indications. The license grants Helix the right to use the antibody in multiple systems, including CAR T cells, in combination with conjugates of the biotech's...
21:11 , Dec 30, 2016 |  BC Week In Review  |  Financial News

Helix BioPharma completes private placement

Helix raised C$1.8 million ($1.4 million) through the sale of units at C$1.20 in a private placement. Each unit comprises a share and a five-year warrant to purchase a share at C$1.50. Helix BioPharma Corp. (TSX:HBP),...
07:00 , Sep 5, 2016 |  BC Week In Review  |  Financial News

Helix completes private placement of units

Helix BioPharma Corp. (TSX:HBP), Aurora, Ontario   Business: Drug delivery, Proteomics, Cancer   Date completed: 2016-08-19   Type: Private placement of units   Raised: C$1 million ($773,800)   Price: C$1.54 (unit)   Shares outstanding prior: 89.2 million   Note: Each unit comprises...
07:00 , Apr 25, 2016 |  BC Week In Review  |  Financial News

Helix completes private placement of units

Helix BioPharma Corp. (TSX:HBP), Aurora, Ontario   Business: Cancer, Drug delivery, Proteomics   Date completed: 2016-04-15   Type: Private placement of units   Raised: C$4.7 million ($3.6 million)   Price: C$1.50 (unit)   Shares outstanding prior: 84.7 million   Note: The amount...
00:09 , Apr 2, 2016 |  BC Extra  |  Company News

Management tracks

Fertility company OvaScience Inc. (NASDAQ:OVAS) said Arthur Tzianabos stepped down as president and CSO. The company promoted James Luterman to SVP from VP of R&D. Oncology play Helix BioPharma Corp. (TSX:HBP) said Zbigniew Markowski is...
07:00 , Sep 14, 2015 |  BC Week In Review  |  Clinical News

L-DOS47: Interim Phase I/II data

Interim data from 40 patients with inoperable, locally advanced, recurrent or metastatic non-squamous stage IIIb/IV NSCLC in the first 12 dosing cohorts of the open-label, Polish Phase I/II LDOS002 trial showed that 0.12-4.33 ug/kg doses...